Submitted by Anonymous (not verified) on 9 October 2025 - 16:10
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Status: Authorised